Cargando…

Cyclophosphamide abrogates the expansion of CD4(+)Foxp3(+) regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas

OBJECTIVE: Promotion of the proliferative expansion of CD4(+)Foxp3(+) regulatory T cells (Tregs) is one of the side effects that limits the use of bleomycin (BLM) in the treatment of tumors. In this study, we examined the hypothesis that cyclophosphamide (CY), a chemotherapeutic agent with the capac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ping, Chen, Fengyang, Zheng, Jingbin, Yang, Yang, Li, Yuan, Wang, Yifei, Chen, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610150/ https://www.ncbi.nlm.nih.gov/pubmed/34378880 http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0027

Ejemplares similares

The role of CD4(+)FoxP3(+) regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment
por: Wang, Yifei, et al.
Publicado: (2021)

The p38 MAPK Inhibitor SB203580 Abrogates Tumor Necrosis Factor-Induced Proliferative Expansion of Mouse CD4(+)Foxp3(+) Regulatory T Cells
por: He, Tianzhen, et al.
Publicado: (2018)

Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury
por: Rey-Parra, G. J., et al.
Publicado: (2012)

Clonogenic assays in the B16 melanoma: response to cyclophosphamide.
por: Steel, G. G., et al.
Publicado: (1977)

MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2
por: Jiang, Mengmeng, et al.
Publicado: (2022)

Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis
por: Scott-Browne, James P., et al.
Publicado: (2007)

Naringin prevents cyclophosphamide-induced erythrocytotoxicity in rats by abrogating oxidative stress
por: Akamo, Adio J., et al.
Publicado: (2021)

ICOS controls Foxp3(+) regulatory T-cell expansion, maintenance and IL-10 production during helminth infection
por: Redpath, Stephen A, et al.
Publicado: (2013)

FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development
por: Haque, Rizwanul, et al.
Publicado: (2010)

Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4(+)Foxp3(+) regulatory T cells
por: He, Tianzhen, et al.
Publicado: (2020)

Expression of Foxp3, CD25 and IL-2 in the B16F10 cancer cell line and melanoma is correlated with tumor growth in mice
por: MIRANDA-HERNÁNDEZ, D.F., et al.
Publicado: (2013)

FOXP3 in Melanoma with Regression: Between Tumoral Expression and Regulatory T Cell Upregulation
por: Cioplea, Mirela, et al.
Publicado: (2020)

Topical Application of Tetrandrine Nanoemulsion Promotes the Expansion of CD4(+)Foxp3(+) Regulatory T Cells and Alleviates Imiquimod-Induced Psoriasis in Mice
por: Chen, Shaokui, et al.
Publicado: (2022)

Correction: FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development
por: Haque, Rizwanul, et al.
Publicado: (2012)

Sox10 Controls Migration of B16F10 Melanoma Cells through Multiple Regulatory Target Genes
por: Seong, Ikjoo, et al.
Publicado: (2012)

TNFR2 deficiency impairs the growth of mouse colon cancer
por: Li, Ping, et al.
Publicado: (2023)

Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma
por: Huang, Lili, et al.
Publicado: (2021)

Regulatory T Cells in Melanoma Revisited by a Computational Clustering of FOXP3(+) T Cell Subpopulations
por: Fujii, Hiroko, et al.
Publicado: (2016)

Effects of T-cadherin expression on B16F10 melanoma cells
por: DUAN, XIN-SUO, et al.
Publicado: (2013)

Inflammation-Driven Reprogramming of CD4(+)Foxp3(+) Regulatory T Cells into Pathogenic Th1/Th17 T Effectors Is Abrogated by mTOR Inhibition in vivo
por: Yurchenko, Ekaterina, et al.
Publicado: (2012)

Chamaejasmin B Decreases Malignant Characteristics of Mouse Melanoma B16F0 and B16F10 Cells
por: Si, Lingling, et al.
Publicado: (2020)

Effects of heavy ions ((12)C(6+)) on malignant melanoma B16F10 cells
por: Zhang, Li-Ping, et al.
Publicado: (2022)

FOXP3+ regulatory T cells and the immune escape in solid tumours
por: Qiu, Yiran, et al.
Publicado: (2022)

Functional Reprogramming of Regulatory T cells in the absence of Foxp3
por: Charbonnier, Louis-Marie, et al.
Publicado: (2019)

Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice
por: M.Gaspal, Fabrina, et al.
Publicado: (2011)

The Expansion of CD25(high)IL-10(high)FoxP3(high) B Regulatory Cells Is in Association with SLE Disease Activity
por: Vadasz, Zahava, et al.
Publicado: (2015)

Neuropilin 1 deficiency on CD4(+)Foxp3(+) regulatory T cells impairs mouse melanoma growth
por: Hansen, Wiebke, et al.
Publicado: (2012)

HDAC10 deletion promotes Foxp3(+) T-regulatory cell function
por: Dahiya, Satinder, et al.
Publicado: (2020)

UXT is a novel regulatory factor of regulatory T cells associated with Foxp3
por: Li, Weina, et al.
Publicado: (2014)

Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib
por: Valpione, Sara, et al.
Publicado: (2015)

Anti-tumor effect of adenovirus-mediated gene transfer of pigment epithelium-derived factor on mouse B16-F10 melanoma
por: Yang, Li-Ping, et al.
Publicado: (2009)

Antiproliferative effect of the jararhagin toxin on B16F10 murine melanoma
por: Maria, Durvanei Augusto, et al.
Publicado: (2014)

Oral Tolerance to Cancer Can Be Abrogated by T Regulatory Cell Inhibition
por: Whelan, Maria C., et al.
Publicado: (2014)

The Regulatory T-cell Transcription Factor Foxp3 Protects against Crescentic Glomerulonephritis
por: Yang, Chen, et al.
Publicado: (2017)

Prenylated Flavonoids from Roots of Glycyrrhiza uralensis Induce Differentiation of B16-F10 Melanoma Cells
por: Zheng, Yunfeng, et al.
Publicado: (2018)

The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma – an immunohistochemical study
por: Salmi, Satu, et al.
Publicado: (2021)

Human FOXP3(+) T regulatory cell heterogeneity
por: Mohr, Audrey, et al.
Publicado: (2018)

Quercetin abrogates chemoresistance in melanoma cells by modulating ΔNp73
por: Thangasamy, Thilakavathy, et al.
Publicado: (2010)

Foxp3 enhancers synergize to maximize regulatory T cell suppressive capacity
por: Zong, Xinying, et al.
Publicado: (2021)

Low expression and hypermethylation of FOXP3 in regulatory T cells are associated with asthma in children
por: Zhu, Xiaohua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e0j8oiphgitsor5hvn4o1gk3bl